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Introduction
Emerin is a type II integral membrane protein residing prin-
cipally at the inner nuclear membrane (INM) (Manilal et al., 
1998), where it interacts with a number of other proteins such 
as lamin A/C (Vaughan et al., 2001) barrier-to-autointegration 
factor (Lee et al., 2001) and β-catenin (Markiewicz et al., 
2006). Emerin has also been shown to interact with pro-
teins that are principally found at the outer nuclear membrane 
(ONM), namely nesprin 1α (Mislow et al., 2002) and nesprin 2 
(Zhang et al., 2005). Emerin was identified by positional 
  candidate cloning as the gene responsible for the X-linked 
form of Emery Dreifuss muscular dystrophy (EDMD) (Bione 
et al., 1994). The autosomal-dominant form of the disease is 
caused by mutations in the gene LMNA, which encodes lamins 
A and C (Bonne et al., 1999). Two hypotheses have been for-
mulated to explain why ubiquitously expressed proteins such 
as emerin, lamin A, and lamin C should cause such highly 
tissue-specifi  c diseases. These are referred to as the “structural” 
and the “gene expression” hypotheses. The gene expression 
hypothesis proposes that emerin and lamins are involved in 
tissue-specifi  c gene expression and disease may arise from the 
downstream effects of mutations on chromatin structure or 
gene expression (Cohen et al., 2001). The structural hypothesis 
proposes that emerin and lamins contribute to the structural 
integrity of the cell by acting as a load-bearing center under-
neath the nuclear envelope (NE) (Hutchison, 2002). In this hypo-
thesis, absence of emerin or lamins in disease would render 
contractile cells like skeletal and cardiac muscle vulnerable to 
damage, leading to cell death and tissue damage (Hutchison 
et al., 2001).
Supporting the structural hypothesis, there is accumulating 
evidence that the NE is closely linked and connected to its 
surrounding cytoskeleton. Work on two protein families, the 
nesprins and Sun proteins, reveals the existence of “bridging” 
complexes, referred to as the LINC complexes, which span 
the NE, thus connecting, the INM with the actin cytoskeleton 
(Crisp et al., 2006). A recent study showed that disorganiza-
tion of the actin, vimentin, and tubulin cytoskeletons arose as 
a consequence of the absence of lamins A and C in mouse em-
bryonic fi  broblasts (Broers et al., 2004), directly supporting the 
idea that the NE is a load-bearing center in animal cells. Here, 
we investigate how absence of emerin in human fi  broblasts 
affects cytoskeleton organization. We show that emerin inter-
acts with β-tubulin to anchor the centrosome at the ONM. This 
unexpected fi  nding provides further support for the structural 
hypothesis and provides the fi  rst clue as to how the tubulin cyto-
skeleton is connected to the NE.
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T
he type II inner nuclear membrane protein emerin is 
a component of the LINC complex that connects the 
nuclear lamina to the actin cytoskeleton. In emerin-
null or -deﬁ  cient human dermal ﬁ  broblasts we ﬁ  nd that 
the centrosome is detached from the nucleus. Moreover, 
following siRNA knockdown of emerin in wild-type ﬁ  bro-
blasts, the centrosome also becomes detached from the 
nucleus. We show that emerin interacts with tubulin, and 
that nocadozole-treated wild-type cells phenocopy the 
  detached centrosome characteristic of emerin-null/deﬁ  cient 
cells. We also ﬁ  nd that a signiﬁ  cant fraction of emerin is 
located at the outer nuclear membrane and peripheral ER, 
where it interacts directly with the centrosome. Our data 
provide the ﬁ  rst evidence in mammalian cells as to the 
  nature of the linkage of the centrosome, and therefore the 
tubulin cytoskeleton, with the outer nuclear membrane.
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Results and discussion
We wished to investigate whether cytoskeletal abnormalities are 
induced by the absence of emerin in cells. To this end, human 
dermal fi  broblasts (HDF) from healthy individuals and from 
X-EDMD patients (which were null for emerin) were investigated 
for possible abnormalities in the actin, vimentin, and tubulin 
cytoskeleton (Fig. 1). In stark contrast to fi  ndings in lamin A/C-
null mouse embryonic fi  broblasts, there were little or no differ-
ences in the organization of any of the cytoskeletal elements in 
emerin-null HDFs. Surprisingly, however, we did observe that 
the centrosome was not positioned next to the nucleus in emerin-
null HDFs (Fig. 1, arrowheads).
To confi  rm this fi  nding, we used an antibody against peri-
centrin to specifi  cally investigate the position of the centrosome. 
In normal HDF the centrosome was positioned next to or within 
1.5 μm of the NE. In contrast, in four independent emerin-null 
HDF cell lines the centrosome was >3.0 μm distant from the 
NE (Fig. 2 A). To further investigate this phenomenon we 
looked at centrosome position in a cell line from an X-EDMD 
carrier, which has approximately equal numbers of emerin-
  positive and emerin-null cells. We found that in emerin-positive 
cells the centrosome was positioned next to the NE, whereas in 
emerin-negative cells the centrosome was >3.0 μm away from 
the NE. Finally, we investigated the centrosome position in a 
  lamin A/C–null HDF line in which emerin was located entirely 
within the endoplasmic reticulum (Muchir et al., 2000). In the 
lamin A/C–null cell line the centrosome was also >3.0 μm 
away from the NE, indicating that absence of emerin from the 
NE was the cause of the centrosome mislocalization (Fig. 2 B). 
To confi  rm that mislocalization of the centrosome was specifi  c 
to absence of emerin from the NE, we investigated centrosome 
positions in a fi  broblast cell line from a patient with Greenberg 
dysplasia, which were null for the INM protein lamin B recep-
tor (LBR) (Waterham et al., 2003). Like EDMD, Greenberg 
dysplasia and the related disorder Pelger-Huey anomaly are 
characterized by nuclear morphological defects (Hoffman et al., 
2002). However, in LBR-null fi  broblasts, emerin was located at 
the NE and similarly the centrosome was positioned adjacent 
to the NE (Fig. 2, B and C), suggesting that centrosome mis-
localization is specifi  c to loss of emerin from the NE. To verify 
these results, we performed knockdown of emerin by siRNA 
in normal HDFs (Fig. 2, D–F). In HDFs transfected with the 
scrambled siRNA, centrosomes were found adjacent to the 
NE. In contrast, in HDFs that were transfected with siRNA spe-
cifi  c for emerin, the centrosome was located at a distance of 
>3.0 μm away from the NE, similar to the distances observed 
in X-EDMD cells.
This very intriguing result raised the important question 
of how a protein that is localized in the INM could affect the 
position of the centrosome, an organelle that is localized at the 
ONM. To investigate whether a yet-unidentifi  ed emerin binding 
partner could help explain the observed phenomenon, we used 
recombinant emerin peptides in coprecipitation experiments 
to identify new emerin binding partners. The peptide was used 
as a bait to precipitate interacting partners from the Xenopus 
egg extracts, which were in turn chosen because they store 
very large quantities of cytoskeleton and centriolar proteins in a 
Figure 1.  Organization of the cytoskeleton in X-EDMD cells. Normal and emerin-null HDFs were ﬁ  xed with methanol/acetone (1:1) and stained for β-actin, 
vimentin, and β-tubulin. No differences in the organization of the cytoskeleton between normal and emerin-null cells were observed, except for the position 
of the centrosome (arrowheads) relative to the NE. While in normal cells the centrosome is positioned next to the NE, in X-EDMD cells it localizes some dis-
tance from the NE. Chromatin was stained with DAPI. Bar, 10 μm.EMERIN AFFECTS CENTROSOME POSITION • SALPINGIDOU ET AL. 899
  soluble form (Fig. 3 A). Bands that coprecipitated with emerin 
were cut from the gel and identifi  ed by mass spectrometry. 
 Interestingly,  β-tubulin was identifi  ed as the most consistent 
emerin binding protein in this assay. To confi  rm that emerin is a 
microtubule (MT) binding protein, MT cosedimentation experi-
ments were performed in which purifi  ed MTs were polymerized 
by taxol and incubated with the same emerin peptide (aa 73–180) 
or two different emerin peptides corresponding to its chromatin 
binding domain (aa 1–70)  or most of the nucleoplasmic domain 
(aa 1–176) (Fig. 3 B). Emerin 73–180 and 1–176 effi  ciently 
cosedimented with MTs, whereas emerin 1–70 did not bind 
to MTs. To estimate the stoichiometry of emerin/microtubule 
Figure 2.  Distance of the centrosome from the nucleus in normal and EDMD cells. (A) The position of the centrosome relative to nucleus was determined in 
nine cell lines: two normal, four emerin null, one X-EDMD carrier, one AD-EDMD cell line (LMNA−/−), and (C) one LBR−/− cell line. Centrosomes were 
visualized in methanol/acetone-ﬁ  xed cells with a rabbit polyclonal pericentrin antibody (TRITC) and NEs were stained with mAb Lamin A/C (FITC), except 
LMNA−/− X-EDMD carrier and LBR−/− cells, which were stained with mAb emerin (FITC) or anti-LBR (TRITC). Chromatin was stained with DAPI. The dis-
tance from the center of each centrosome to the NE was measured and images representative of each cell line using AxioVision (Carl Zeiss MicroImaging, 
Inc.) software are shown. Bars, 10 μm. (B) Nuclear–centrosome distances were measured in 200 cells for each cell line in triplicate experiments. The mean 
distances (μm) ± SEM are displayed in a bar chart. (D) HDFs were treated with siRNA against emerin or as a control scrambled siRNA. 48 h later, ﬁ  xed 
cells were stained for pericentrin (TRITC) and emerin (FITC). After speciﬁ  c knockdown, 70% of HDFs were negative for emerin. Nuclear–centrosome dis-
tances were measured in cells using AxioVision (Carl Zeiss MicroImaging, Inc.) software as described above. For statistical analysis (E) the mean distance 
(μm) ± SEM was determined in samples of 200 cells in triplicate experiments for control, siRNA emerin +ve, or siRNA emerin −ve HDFs. (F) Western 
  blotting was performed on siRNA-treated HDFs to compare the relative amounts of emerin in control (lane 1) and knock-down cultures (lane 2).JCB • VOLUME 178 • NUMBER 6 • 2007  900
interactions we calculated the tubulin/emerin binding ratios. 
Emerin 1–176 bound to tubulin at an approximate ratio of 1:8, 
which is close to the binding ratios of known microtubule-
  associated proteins (MAPs) (e.g., Enconsin; Bulinski and Bossler, 
1994). Emerin 73–180 bound to tubulin at an approximate ratio 
of 1:24, and this weaker interaction is likely due to misfolding 
of this peptide. Collectively, these data suggest that emerin is 
a novel MT-interacting protein.
The interaction of emerin with β-tubulin led us to investi-
gate whether MTs are involved in the attachment of the centro-
some to the NE. To investigate this possibility, normal and 
X-EDMD fi  broblasts were treated with nocodazole and its ef-
fects on MT organization and centrosome position were investi-
gated (Fig. 3, C and D). As expected, nocodazole treatment led 
to the depolymerization of the MT network. Interestingly, when 
normal HDFs were treated with nocodazole the centrosome was 
observed to be located >3.0 μm away from the NE, just as was 
observed in emerin-null fi  broblasts. As a control, normal HDFs 
were treated with latrunculin B to depolymerize the actin cyto-
skeleton. In latrunculin B–treated HDFs the centrosome was 
located adjacent to the NE, implying that only disruption of the 
tubulin cytoskeleton leads to an emerin-null phenocopy. We 
confi  rmed this fi  nding using biochemical fractionation to deter-
mine whether centrosomes cosedimented with the nucleus in a 
range of HDF lines (Fig. S1, available at http://www.jcb.org/
cgi/content/full/jcb.200702026/DC1). In normal HDFs, nuclei 
and centrosomes cosedimented at a 1:1 ratio. In emerin-null HDFs 
or normal HDFs treated with nocodazole, nuclei and centrosomes 
cosedimented at a 1:0.4 ratio, again showing that centrosomes 
were detached from the NE.
All the above experiments provide strong evidence that 
emerin links centrosomes to the NE via a MT association. Given 
that emerin is a protein of the INM, this raised the question as to 
whether emerin acts via another protein that crosses the NE. We 
therefore investigated whether either SUN domain proteins or 
one of the nesprins is also mislocalized in emerin- null HDFs 
as a fi  rst step to determining whether these proteins might be 
involved in centrosome localization. We could not detect any 
change in the distribution of SUN1 or nesprin 1 (not depicted) or 
SUN2 or nesprin 2 (Fig. S2, available at http://www.jcb.org/cgi/
Figure 3.  Emerin–𝗃-tubulin interaction and its implications 
for centrosome position. (A) A His-tagged recombinant emerin 
peptide corresponding to aa 73–180 was immobilized on 
Ni
2+-beads and used to pull down binding partners from 
cytosolic fractions of Xenopus egg extracts. Proteins that 
co  eluted with emerin after treatment of the beads with Ni
2+ 
were resolved by SDS-PAGE (lane 4). As a control, Xenopus 
cytosol was incubated with the beads in absence of emerin 
peptides (lane 2). The puriﬁ  ed emerin peptide on its own is 
shown in lane 3. Molecular weight markers are shown in lane 1. 
Arrowhead indicates the band that was selected as a potential 
emerin binding partner and was identiﬁ  ed by Maldi-TOF 
mass spectroscopy as β-tubulin (Mascot score = 166). 
(B) MTs were polymerized by taxol and incubated with emerin 
peptides 1–70, 73–180, or 1–176. The relative proportion 
of emerin collected in pellet fractions after centrifugation at 
200,000 g, in the presence (gray bars) or absence (white 
bars) of MTs, was determined by densitometry performed on 
Coomassie-stained SDS-PAGE and is presented as the mean ± 
SEM of three independent experiments in a bar chart. 
(C) Normal HDFs were treated either with nocodazole or with 
latrunculin B to depolymerize MTs and actin, respectively. Cells 
were then ﬁ  xed and stained with anti-pericentrin (FITC) and 
anti–β-tubulin (Cy3) or anti-actin (TRITC) antibodies. Chromatin 
was visualized with DAPI. Nuclear–centrosome distances were 
measured in 200 cells in triplicate experiments for each cell 
line. Results (D) are expressed as mean distances (μm) ± SEM 
in bar charts.EMERIN AFFECTS CENTROSOME POSITION • SALPINGIDOU ET AL. 901
content/full/jcb.200702026/DC1) in these cells, suggesting that 
these proteins were not involved in centrosome localization. As 
a result of this fi  nding we decided to reinvestigate the localization 
of emerin in normal fi  broblasts. Using digitonin permeabili-
zation, we showed that a considerable fraction of emerin was 
concentrated at the ONM, with a further dispersed fraction in 
Figure 4.  Digitonin permeabilization of normal and X-EDMD HDFs. (A) Normal HDFs were permeabilized with digitonin and stained for emerin with two 
antibodies: a mouse monoclonal (4G5) and a rabbit polyclonal (AP8) antibody. Cells were also stained for lamin A/C and for Sun 2. Digitonin treatment 
selectively permeabilizes the plasma membrane, leaving the NE intact, therefore rim staining with emerin represents staining of the ONM. Bar, 10 μm. 
(B) Normal HDFs that were used to knock down emerin by siRNA were stained for emerin (mAb 4G5) after digitonin permeabilization. As a control, cells 
treated with scrambled siRNA are shown. Also X-EDMD cells, which are emerin null and cells from an X-EDMD carrier, which are a mixture of emerin +ve 
and −ve cells, were also permeabilized with digitonin and stained with emerin mAb 4G5. Bar, 10 μm. (C) Normal HDFs were transfected with a Sun1 
construct that encodes the soluble Sun1 lumenal domain and displaces Nesprin 2 from the ONM, were permeabilized with digitonin, and were stained for 
Sun1 (FITC) and emerin (TRITC). Emerin localization at the ONM does not seem to depend on Nesprin 2.JCB • VOLUME 178 • NUMBER 6 • 2007  902
the peripheral ER, with two independent anti-emerin anti-
bodies, whereas lamins A/C and SUN2 were undetectable under 
similar conditions and therefore located exclusively at the INM 
(Fig. 4 A). The anti-Sun2 antibody used in this assay recognizes 
a luminal domain, indicating that not only is the INM intact, but 
also the ONM, strengthening the fi  nding that a fraction of emerin 
resides at the ONM. To confi  rm that the protein detected at the 
ONM was indeed emerin, we performed siRNA knockdown 
of emerin on control fi  broblasts and again stained the cells 
with anti-emerin antibodies after digitonin permeabilization. In 
these experiments knockdown was  70% effi  cient, and whereas 
emerin was detected at the ONM in fi  broblasts treated with 
scrambled siRNA, staining was eliminated in cells transfected 
with siRNA specifi  c to emerin (Fig. 4 B). As a further control we 
also stained X-EDMD fi  broblasts, (which are null for emerin) 
or an X-EDMD carrier in which emerin is absent from  50% 
of cells. We found that staining of the ONM was undetectable 
in emerin-null fi  broblasts, further supporting the presence of 
emerin at the ONM. This fi  nding implies that emerin residing at 
the ONM can interact directly with centrioles via MTs. It has 
recently been reported that localization of emerin at the INM is 
dependent upon the presence of both nesprin1α and 2β (Wheeler 
et al., 2007). To investigate whether nesprins might also be 
involved in localization of emerin to the ONM, we transfected 
normal HDF with a dominant-negative Sun1 mutant that causes 
loss of the ONM form of nesprin 2 (Crisp et al., 2006). We found 
that emerin was still detected at the ONM in the presence of this 
mutant, suggesting that nesprin2 does not cause the localization 
of emerin to the ONM (Fig. 4 C).
Overall, our results show that emerin interacts directly with 
MTs and that emerin and MTs both are necessary for the asso-
ciation of the centrosome with the NE. Our fi  ndings are sup-
ported by previous work, which showed a colocalization of 
emerin with β-tubulin in mitotic cells (Dabauvalle et al., 1999) 
and an enrichment of emerin at the kinetochores, near the spindle 
poles, during NE reassembly (Haraguchi et al., 2000). Recent 
evidence has demonstrated how complexes involving lamins A/C, 
the SUN domain proteins, and the nesprins link the actin and 
intermediate fi  lament cytoskeletons to the NE in mammalian 
cells (Wilhelmsen et al., 2005; Crisp et al., 2006). Our current 
data now reveal how the tubulin cytoskeleton via the centriole 
interacts with the NE in human fi  broblasts.
Materials and methods
Cell culture
HDF cells and LBR-null cells (provided by K. Hoffmann, Charité Humboldt 
University, Berlin, Germany) were grown in DME supplemented with 
10 U/ml penicillin, 50 μg/ml streptomycin, and 10% vol/vol NCS, and 
maintained at 37°C in a humidiﬁ  ed atmosphere containing 5% CO2 until 80% 
conﬂ  uence. Serial passage was performed in the presence of trypsin and 
0.5% EDTA.
Immunoﬂ  uorescence and confocal microscopy
HDFs were ﬁ  xed with methanol/acetone (1:1) on ice for 5 min or with 4% 
paraformaldehyde for 12 min at RT followed by permeabilization either 
with 1% Triton X-100 (for 5 min at RT) or with Digitonin (40 μg/ml for 
2 min, on ice). Primary antibodies used and their dilutions are described 
in Table I. Anti-Sun2 was provided by B. Burke (University of Florida, 
Gainesville, FL) and anti-Nesprin 2 K1 antibody was provided by 
I. Karakesisoglou (University of Cologne, Cologne, Germany). FITC- or 
TRITC-conjugated secondary antibodies were obtained from Stratech and 
chromatin was visualized with DAPI/Mowiol.
For imaging, a confocal microscope (LSM510 META; Carl Zeiss 
MicroImaging, Inc.) with LSM510 image browser software (Carl Zeiss Micro-
Imaging, Inc.) was used at ambient temperature, equipped with 40×/1.3 
and 63×/1.4 oil-immersion lenses and a non-imaging photodetection 
device (photomultiplier tube; Carl Zeiss MicroImaging, Inc.). A dynamic 
range adjustment was used to optimize the signal for the ﬂ  uorophores, and 
images were collected in multitrack mode. Any brightness and contrast 
adjustments were performed in Adobe Photoshop.
Gel electrophoresis and immunoblotting
One-dimensional SDS-PAGE was performed according to Laemmli (1970). 
For immunoblotting, proteins were transferred onto nitrocellulose mem-
branes (Schleicher & Schuell) using the Mini Trans-Blot system (Bio-Rad 
Laboratories). HRP-conjugated secondary antibodies were obtained from 
Jackson ImmunoResearch Laboratories. Bands were visualized by en-
hanced chemiluminescence (ECL reagents; GE Healthcare).
siRNA
Emerin-speciﬁ  c siRNA duplexes were obtained from Ambion. The sequence 
of sense nucleotides was as follows: 5′-G  G  U  G  G  A  U  G  A  U  G  A  C  G  A  U  C  U-
U  tt-3′. RNAi transfection procedure was performed as in Harborth et al. 
(2001). Speciﬁ  c silencing of emerin was conﬁ  rmed by three indepen-
dent experiments.
Protein puriﬁ  cation and coprecipitation experiments
Histidine-tagged emerin peptides were expressed in bacteria, extracted as sol-
uble peptides, and puriﬁ  ed on Ni-NTA–Agarose beads (QIAGEN) by immobi-
lized metal afﬁ  nity chromatography according to the QIAGEN protocol.
For the pull-down experiments, puriﬁ  ed emerin peptide 73–180 
was immobilized on Ni-beads and incubated with the cytosolic fraction 
of Xenopus egg extracts for 4 h at 4°C, on a roller. Non-speciﬁ  c binding 
was removed with 250-mM NaCl washes. Emerin together with co-eluting 
proteins were resolved by SDS-PAGE. Xenopus egg extracts were pre-
pared and fractionated to generate membrane-free cytosol as described by 
Drummond et al. (1999).
Table I. Antibodies used in this study
Antibody Antigen Host IF dilution IB dilution Source/Reference
Emerin clone 4G5 Emerin Mouse 1:30 1:250 Vector Inc.
Emerin AP8 Emerin Rabbit 1:250 – ImmuQuest
Anti-tubulin β-tubulin Mouse 1:100 – Sigma-Aldrich
Pericentrin Pericentrin Rabbit 1:400 – Abcam
JOL2 Lamin A/C Mouse 1:30 – Dyer et al., 1997
AC-40 β-actin Mouse 1:300 1:2,000 Sigma-Aldrich
Vimentin clone v9 Vimentin Mouse 1:100 – Sigma-Aldrich
Anti-Sun 2 Sun 2 Mouse 1:100 – Crisp et al., 2006
Anti-Nesprin 2 K1 Nesprin 2 Rabbit 1:50 – Libotte et al., 2005
Anti-LBR Lamin B receptor Rabbit 1:250 – Abcam
Anti-HA Hemagglutinin Mouse 1:50 – AbcamEMERIN AFFECTS CENTROSOME POSITION • SALPINGIDOU ET AL. 903
MT-binding assays
Tubulin was puriﬁ   ed from bovine brain according to the method of 
  Shelanski et al. (1973). Microtubules were polymerized in the presence of 
taxol as described previously (Smertenko et al., 2004). 10 μg of puriﬁ  ed 
emerin peptides 1–70 and 73–180 were mixed with 20 μg of taxol-stabi-
lized MTs and centrifuged at 200,000 g. No MTs were added to control 
samples. Samples were analyzed by SDS-PAGE. The amount of the emerin 
fragments was quantiﬁ  ed in the gel using NIH Image software and normal-
ized by the mean. To measure the relative binding ratio of tubulin to emerin 
in the microtubules, microtubule cosedimentation assays were performed 
as described above, then the samples were separated by SDS-PAGE and 
Coomassie brilliant blue R-250 was used to stain the gels. The gels were 
quantiﬁ  ed using NIH Image software. The average density values were 
multiplied by the measured area values to get the absolute intensity, and 
then the background values were subtracted from the protein band values. 
The tubulin/emering binding ratio was calculated using the following 
equation assuming that tubulin is present as heterodimer and emerin frag-
ment as monomer: R = (I
tubulin × Mr
emerin)/(2 × I
emerin × Mr
tubulin), where I is 
absolute intensity for the corresponding protein band and Mr is molecular 
mass (50 kD for tubulin, 22 kD for aa 1–176 fragment, and 15 kD for aa 
73–180 fragment).
Transfection of normal HDF with the Sun1 construct
Normal HDFs were transfected with 2 μg of plasmid SS-HA-Sun1L-KDEL   
(Crisp et al., 2006) with the Amaxa Biosystems Nucleofection system using 
the Basic Nucleofector kit for primary mammalian ﬁ  broblasts (VPI-1002) as 
described by the manufacturer. Cells were ﬁ  xed 24 h after transfection with 
4% paraformaldehyde and underwent sequential permeabilization. Cells 
were initially permeabilized with digitonin and stained with the rabbit-
emerin AP8 antibody. Cells were then ﬁ  xed again with 4% paraformalde-
hyde incubated with 1% Triton X-100 and stained with a mouse-HA tag 
antibody to detect the Sun1 construct.
Nuclear isolation experiments
Cells were grown to 90% conﬂ  uence and collected by centrifugation. Cell 
pellets were resuspended in Nuclear Isolation Buffer (NIB) (250 mM NaCl, 
3 mM MgCl, 10 mM Tris-HCL, pH 7.6, 0.5% Nonidet, and protease inhibitor 
cocktail; 1 ml NIB/10
6 cells) and incubated on ice for 15 min. Nuclei were 
released with a Wheaton homogenizer and isolated on coverslips by centrifu-
gation (4,000 rpm for 10 min at 4°C) through a 30% sucrose cushion.
Online supplemental material
Fig. S1 shows nuclear isolation experiments in normal and X-EDMD cells 
with increased salt concentration. Fig. S2 shows Sun 2 and Nesprin 2 stain-
ing in normal and X-EDMD HDFs. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200702026/DC1.
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